MARVERTI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.963
EU - Europa 4.986
AS - Asia 1.641
SA - Sud America 48
OC - Oceania 10
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.914
GB - Regno Unito 1.501
IT - Italia 1.090
SE - Svezia 607
SG - Singapore 573
DE - Germania 552
CN - Cina 542
FR - Francia 288
UA - Ucraina 180
PL - Polonia 174
HK - Hong Kong 168
FI - Finlandia 144
RU - Federazione Russa 120
TR - Turchia 108
BG - Bulgaria 85
ID - Indonesia 75
IN - India 61
IE - Irlanda 55
BE - Belgio 54
CA - Canada 48
LT - Lituania 41
BR - Brasile 34
JP - Giappone 24
CZ - Repubblica Ceca 22
VN - Vietnam 22
NL - Olanda 21
KR - Corea 15
MY - Malesia 14
CH - Svizzera 13
TW - Taiwan 11
ES - Italia 8
RO - Romania 8
CL - Cile 7
IR - Iran 7
AU - Australia 6
DK - Danimarca 6
GR - Grecia 6
AR - Argentina 4
EU - Europa 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
NO - Norvegia 3
AT - Austria 2
AZ - Azerbaigian 2
EG - Egitto 2
MO - Macao, regione amministrativa speciale della Cina 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BD - Bangladesh 1
BH - Bahrain 1
BY - Bielorussia 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
NP - Nepal 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TZ - Tanzania 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 16.658
Salva come PNG Salva come JPEG
Città #
Fairfield 1.252
Southend 1.185
Santa Clara 1.161
Woodbridge 827
Chandler 796
Ashburn 747
Ann Arbor 540
Seattle 506
Houston 501
Cambridge 434
Wilmington 404
Nyköping 378
Jacksonville 372
Dearborn 358
Singapore 353
Modena 271
Frankfurt am Main 210
Kraków 169
Hong Kong 159
New York 136
San Diego 120
Beijing 110
Princeton 89
Helsinki 85
Sofia 84
Eugene 79
Fremont 77
Jakarta 75
Izmir 69
Bologna 59
Moscow 53
Dublin 52
London 49
Boardman 47
Brussels 44
Shanghai 44
Redwood City 42
Munich 39
Milan 35
Parma 35
Des Moines 33
Grafing 28
Ottawa 27
Bremen 25
Norwalk 24
Falls Church 20
Hefei 20
Brno 19
Dong Ket 19
San Mateo 19
Guangzhou 18
Verona 18
Reggio Emilia 17
Toronto 17
Nanjing 16
Jinan 14
Phoenix 14
Piacenza 14
Washington 14
Augusta 12
Formigine 12
Kunming 12
Rome 12
Auburn Hills 11
Kilburn 11
Osnabrück 11
Paris 11
Los Angeles 10
Padova 10
Ferrara 9
Amsterdam 8
Saint Petersburg 8
Zurich 8
Argenta 7
Bangalore 7
Chiswick 7
Hounslow 7
Leuven 7
Turin 7
Boston 6
Finale Emilia 6
Lappeenranta 6
Monmouth Junction 6
Mountain View 6
Nanning 6
Perugia 6
Rimini 6
Romainville 6
Rossdorf 6
Sassuolo 6
Wuhan 6
Zhengzhou 6
Carovigno 5
Chicago 5
Dallas 5
Detroit 5
Dongguan 5
Hebei 5
Indiana 5
Reggio Nell'emilia 5
Totale 12.727
Salva come PNG Salva come JPEG
Nome #
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 344
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 313
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 297
Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides 280
Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology 277
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 274
Repurposing of drugs targeting yap-tead functions 273
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 271
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells. 254
1H, 13C, 195Pt NMR study on platinum(II) interaction with sulphur containing Amadori compounds 249
Polyamine depletion protects HL-60 cells from 2-deoxy-D-ribose-induced apoptosis. 247
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 247
Translational repression of thymidylate synthase by targeting its mRNA 247
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth 247
The effect of spermine on calcium requirement for protein kinase C association with phospholipid vesicles. 245
Cisplatin-resistance modulates the effect of protein synthesis inhibitors on spermidine/spermine N-1-acetyltransferase expression 245
Spermidine/spermine N1-acetyltransferase transient over-expression restores sensitivity of resistant human ovarian cancer cells to N1,N12-bis(ethyl)spermine and to cisplatin 244
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 241
Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies 235
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and-resistant human ovarian cancer cells 234
Modulation of cis-diamminedichloroplatinum(II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells. 230
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 230
Spermidine/spermine N1-acetyltranferasemodulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistanthuman ovarian cancer cell lines 229
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 221
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 221
Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives 219
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 219
Differential induction of spermidine/spermine N1-acetyltransferase activity in cisplatin-sensitive and -resistant ovarian cancer cells in response to N1,N12-bis (ethyl)spermine involves transcriptional and post-transcriptional regulation. 218
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 217
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 216
PTEROATE-PEPTIDE BIOCONJUGATE TARGETING THE FOLATE RECEPTOR IN HUMAN OVARIAN CANCER CELL LINES: TRANSPORT AND MECHANISM OF ACTION. 208
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 204
Polyamine depletion switches the form of 2-deoxy-D-ribose-induced cell death from apoptosis to necrosis in HL-60 cells. 202
N-1,N-12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines 201
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 200
A proteomic approach to investigate the mechanism of action of anticancer peptides 194
ANTICANCER DRUGS 194
2-Deoxy-D-ribose-induced apoptosis in HL-60 cells is associated with the cell cycle progression by spermidine 194
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 193
Ligand-Based Virtual Screening and ADME-Tox Guided Approach to Identify Triazolo-quinoxalines as Folate Cycle Inhibitors. 193
N-(naphthyl)-N′-(methoxy carbonyl)thiocarbamide and its Cu(I) complex: synthesis, spectroscopic, X-ray, DFT andin vitrocytotoxicity study 192
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 191
Spermine protects protein kinase C from phospholipid-induced inactivation 189
Chairperson EUTROC- Mayo Conference-Berlin - Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cell models. 186
Depletion of Trichoplein (TpMs) Causes Chromosome Mis-Segregation, DNA Damage and Chromosome Instability in Cancer Cells 186
Development of new metal-chelating multi target drus derived from Curcumin 184
Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression 183
Monodentate Coordination of N, N′-Disubstituted Thiocarbamide Ligands: Syntheses, Structural Analyses, In Vitro Cytotoxicity and DNA Damage Studies of Cu(I) Complexes 178
Effect of Spermine on Membrane-Associated and Membrane-Inserted Forms of Protein Kinase C 176
Invited lecture to 18th World Congress on Advances in Oncology and 16th International Symposium on Molecular Medicine 10-12 October, 2013, Creta Maris, Hersonissos, Crete, Greece 175
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 174
Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells 172
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 171
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 171
Copper (I) complexes based on novel N, N'-disubstituted thiocarbamides: Synthesis, spectroscopic, in vitro cytotoxicity, DNA damage and G0/G1 cell cycle arrest studies 170
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 168
Relationship Between Spermine and Calcium on the Activation Process of Protein Kinase C. 164
Synthesis, chemical and biological studies on new Fe3þ-glycosilated b-diketo complexes for the treatment of iron deficiency 164
Synthesis, molecular structure exploration and in vitro cytotoxicity screening of five novel N, N′- disubstituted thiocarbamide derivatives 162
Folate Receptor Expression and Folate Receptor Targeted Chemotherapy in Cisplatin-sensitive and – resistant Human cancer cell lines Marverti G.a, Pirondi S.a, MarracciniC.a, Frassineti C.a, Helleman J.b, Berns E.M.J.J. b, and Costi, M.P. cThe 4th International Symposium on Folate Receptors and Transporters Cozumel, Mexico October 7 - 11, 2012 154
Collateral sensitivity to novel folate cycle inhibitors enhances cisplatin effectiveness against human ovarian cancer cells. 152
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 152
Experimental and theoretical exploration of molecular structure and anticancer properties of two N, N′–disubstituted thiocarbamide derivatives 148
Synthesis, characterization, Hirshfeld surface, cytotoxicity, DNA damage and cell cycle arrest studies of N, N-diphenyl-N'-(biphenyl-4- carbonyl/4-chlorobenzoyl) thiocarbamides 144
Exploring the biological activity of a library of 1,2,5-Oxadiazole derivatives endowed with antiproliferative activity 144
SSAT modulation by putative regulators of folate cycle enzymes expression in cisplatin-sensitive and –resistant human ovarian cancer cell lines. 140
Effect of spermine on association of protein kinase C with phospholipid vesicles. 135
Copper (I) complexes of N-(2/4 methoxy/2-chloro-4-nitro) phenyl-N’ (methoxycarbonyl) thiocarbamides as potential anticancer agents: Synthesis, crystal structure, in vitro cytotoxicity and DNA damage studies. 131
Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered responce in accumulation-defective resistant cells. 127
Glucosyl curcuminoid derivatives: Fe(III) and Ga(III) chelating agents with anti-cancer properties 127
Erratum: Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 34 (E542-E549) DOI: 10.1073/pnas.1104829108) 122
Synthesis, spectroscopic, crystal structure and in vitro cytotoxicity studies of N-thiophenoyl-N'-substituted phenyl thiocarbamide derivatives 121
Differential induction of spermidine/spermine N1-acetyltransferase in cisplatin-sensitive and -resistant human breast cancer cells by N1, N12-bis(ethyl)spermine. 120
Glucosyl curcuminoid derivatives: Fe(III) and Ga(III) chelating agents with anti-cancer properties 120
Effect of spermine on irreversible insertion of protein kinase C into phospholipid vesicles. 114
LC-MS serum proteomics reveals a panel of proteins prognostic of positive responsiveness to bevacizumab therapy in late-stages ovarian cancer patients 111
Effetto delle poliammine sulla regolazione della proteina cinasi C. 111
Structural bases for the synergistic inhibition of human thymidylate synthase and ovarian cancer cell growth by drug combinations 109
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 108
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library 104
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 98
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 97
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 96
Synthesis, characterisation, Hirshfeld surface and in vitro cytotoxicity evaluation of new N-aryl-N0-Alkoxycarbonyl thiocarbamide derivatives. 90
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 85
Structural, Hirshfeld surface and in vitro cytotoxicity evaluation of five new N-aryl-N’-alkoxycarbonyl thiocarbamide derivatives. 84
Telomere Dysfunction Is Associated with Altered {DNA} Organization in Trichoplein/Tchp/Mitostatin ({TpMs}) Depleted Cells 79
Inhibition of cell growth by accumulated spermine is associated with a transient alteration of cell cycle progression 79
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 77
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 75
Cellular uptake and metabolic degradation of a conjugate of folic acid with an anticancer peptide targeting the human Thymidylate synthase enzyme 75
Precision medicine through proteomics studies in drug resistant colorectal cancer 72
Development of a sensitive biochemical tool to assess the expression levels of recombinant ectopic proteins in in vitro engineered cellular systems 71
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 70
Integrating MS proteomics in the Medicinal Chemistry pipeline as powerful tool to overcome drug resistance issues in colorectal cancer 61
Dabrafenib-Panobinostat Salt: Improving Dissolution Rate and Inhibition of BRAF Melanoma Cells 50
Structural insight into YAP-TEAD4 protein-protein interactions as target for cancer treatment 47
Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy 40
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 22
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation 22
Totale 16.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.921 0 0 0 0 0 420 480 308 308 106 158 141
2020/20212.822 234 116 202 244 334 176 224 324 133 445 227 163
2021/20221.929 99 121 162 78 100 206 72 90 230 146 402 223
2022/20232.197 239 284 165 235 228 278 82 250 237 32 91 76
2023/20241.790 61 122 119 107 525 202 73 121 31 48 193 188
2024/20252.322 164 49 145 318 923 723 0 0 0 0 0 0
Totale 16.907